APP and Alzheimer disease: These mice were established by the coinjection of two AD-associated human genes carrying FAD-linked mutations [i.e., APP with the Swedish mutation (KM670/671NL), and MAPT with the P301L mutation] into the embryo of homozygous Psen1 M146V knock-in mice (Oddo et al., 2003).